การประเมินพัฒนาการและผลกระทบในระยะยาวของทารกที่เกิดจากมารดาที่ตรวจพบการใช้สารแอมเฟตามีนระหว่างการตั้งครรภ์: การศึกษาทิศทางคู่
Abstract
Background: Amphetamine use among pregnant women has increased in the Thai-Lao border area of Loei Province, with rates twice the national average. Amphetamines cross the placental barrier and affect fetal neurological growth and development.
Objective: To evaluate the developmental outcomes and long-term effects in infants born to mothers who tested positive for amphetamine use during pregnancy in the Thai-Lao border area of Loei Province.
Methods: A two-phase bidirectional analytical study was conducted. Phase 1 involved a retrospective review of maternal and infant medical records from public hospitals in Loei Province (2020-2023), comparing 32 mothers who tested positive for amphetamine use with 32 matched controls based on maternal age, gestational age, and socioeconomic status. Phase 2 involved developmental follow-up starting at 12 months of age, with assessments every 6 months using DENVER II and Bayley-III scales. Data were analyzed using t-test, Chi-square test, and multiple logistic regression.
Results: Mothers who used amphetamines during pregnancy had a significantly higher rate of low birth weight infants (<2,500 grams) at 46.9% compared to 21.9% in the control group (OR=3.21, p=0.029). The mean birth weight was 237.1 grams lower (p=0.018). Developmental follow-up at 18.3±6.8 months revealed delayed development in all domains among the study group, particularly in language development (OR=7.22, p=0.007) and emotional-social development. Additionally, 42.9% had a 9-fold higher risk of multi-domain developmental delays (p=0.024). The study group showed significantly more attention deficit problems (OR=5.20, p=0.044) and sleep disturbances (OR=3.45, p=0.040) compared to controls.
Conclusion: Amphetamine use during pregnancy adversely affects birth weight and child development. Enhanced prevention measures, improved screening and monitoring systems for at-risk children, and promotion of breastfeeding are recommended to mitigate these effects in border areas.
Implications: Implement enhanced prevention measures for substance use in pregnant women, develop screening and developmental monitoring systems for at-risk children, promote breastfeeding, and establish multidisciplinary care guidelines specifically for border areas.
References
McKetin R, Chalmers J, Sunderland M, Bright DA. Recreational drug use and pregnancy: a systematic review of use and effects. Obstet Gynecol Surv. 2018;73(11):686-96.
United Nations Office on Drugs and Crime. World Drug Report 2023. Vienna: UNODC; 2023.
Oei JL, Melhuish E, Uebel H, Azzam N, Breen C, Burns L, et al. Neonatal abstinence syndrome and high school performance. Pediatrics. 2019;143(2):e20182651.
Wright TE, Terplan M, Ondersma SJ, Boyce C, Yonkers K, Chang G, et al. The role of screening, brief intervention, and referral to treatment in the perinatal period. Am J Obstet Gynecol. 2015;213(4):539-47.
Cruickshank CC, Dyer KR. A review of the clinical pharmacology of methamphetamine. Addiction. 2009;104(7):1085-99.
Gorman MC, Orme KS, Nguyen NT, Kent EJ, Caughey AB. Outcomes in pregnancies complicated by methamphetamine use. Am J Obstet Gynecol. 2018;218(3):336.e1-336.e7.
Department of Mental Health, Ministry of Public Health. National Mental Health Survey of Thai
People 2019. Nonthaburi: Department of Mental Health; 2020. (In Thai)
Loei Provincial Public Health Office. Report on Drug Situation and Maternal and Child Health in Loei Province 2022. Loei: Loei Provincial Public Health Office; 2023. (In Thai)
Smith LM, Diaz SD, LaGasse LL, Derauf C, Newman E, Shah R, et al. Long-term neurodevelopmental consequences of prenatal methamphetamine exposure: A systematic review and meta-analysis. Neurotoxicol Teratol. 2020;77:106850.
LaGasse LL, Derauf C, Smith LM, Newman E, Shah R, Neal C, et al. Prenatal methamphetamine exposure and childhood behavior problems at 3 and 5 years of age. Pediatrics. 2012;129(4):681-8.
Chang L, Cloak C, Jiang CS, Farnham S, Tokeshi B, Buchthal S, et al. Prenatal methamphetamine exposure disrupts dopaminergic system development and alters neurobehavioral outcomes in children. J Neurosci. 2021;41(8):1758-70.
Castel-Kremer E, Martel A, Baudin M, Khoshnood B, Carbajal R, Ancel PY. Prenatal substance exposure and neurodevelopmental outcomes in very preterm infants: A multicenter cohort study. Pediatrics. 2019;144(2):e20183977.
Roussotte FF, Sulik KK, Mattson SN, Riley EP, Jones KL, Adnams CM, et al. Regional brain volume reductions relate to facial dysmorphology and neurocognitive function in fetal alcohol spectrum disorders. Hum Brain Mapp. 2018;39(3):1195-207.
Barker DJ, Osmond C, Golding J, Kuh D, Wadsworth ME. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ. 1989;298(6673):564-7.
Wilson JG. Environment and birth defects. New York: Academic Press; 1973.
Evans GW, Li D, Whipple SS. Cumulative risk and child development. Psychol Bull. 2013;139(6):1342-96.
Smith LM, Diaz SD, LaGasse LL, Derauf C, Newman E, Shah R, et al. Long-term neurodevelopmental consequences of prenatal methamphetamine exposure: A systematic review and meta-analysis. Neurotoxicol Teratol. 2020;77:106850.
Wright TE, Tronick EZ, Smith LM. Prenatal methamphetamine use and birth outcomes: a systematic review. J Matern Fetal Neonatal Med. 2019;32(14):2423-2431.
Smith AB, Johnson CD, Williams EF. Birth weight and neurological complications: a population-based cohort study. Pediatr Res. 2020;87(3):512-519.
Chang L, Smith LM, LoPresti C, Yonekura ML, Ernst T, Buchthal S, et al. Smaller subcortical volumes and cognitive deficits in children with prenatal methamphetamine exposure. Psychiatry Res. 2017;259:20-29.
Castel-Kremer E, Sheinkopf SJ, Lester BM. Prenatal substance exposure and child developmental
outcomes: meta-analysis findings. Early Hum Dev. 2018;118:45-53.
LaGasse LL, Derauf C, Smith LM, Newman E, Shah R, Arria A, et al. Prenatal methamphetamine exposure and childhood behavior problems. Pediatrics. 2012;129(4):681-688.
Roussotte FF, Bramen JE, Nunez SC, Quandt LC, Smith LM, O'Connor MJ, et al. Abnormal brain activation during working memory in children with prenatal exposure to drugs of abuse. Neuroimage. 2011;54(4):3067-3075.
Martinez-Biarge M, Diez-Sebastian J, Kapellou O, Gindner D, Allsop JM, Rutherford MA, et al. Breastfeeding and neurodevelopmental outcomes in high-risk infants. Acta Paediatr. 2019;108(6):1023-1030.
Diaz SD, Smith LM, LaGasse LL, Derauf C, Newman E, Shah R, et al. Effects of prenatal methamphetamine exposure on behavioral and cognitive findings at 7.5 years of age. J Pediatr. 2014;164(6):1333-1338.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Boromarajonani College of Nursing Udonthani

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
